imidazole has been researched along with Carcinoma, Hepatocellular in 1 studies
imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aruchamy, B | 1 |
| Drago, C | 1 |
| Russo, V | 1 |
| Pitari, GM | 1 |
| Ramani, P | 1 |
| Aneesh, TP | 1 |
| Benny, S | 1 |
| Vishnu, VR | 1 |
1 other study available for imidazole and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Imidazole-pyridine hybrids as potent anti-cancer agents.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Glycogen Synthase Kinase 3 beta; Humans; Liver Neo | 2023 |